Through a collaborative partnership between its medical and data science teams, Munich Re Life US has undertaken a large-scale study to further understand the potential significance of GLP-1 drugs
Turpin W, Lee SH, Raygoza Garay JA, Madsen KL, Meddings JB, Bedrani L, Power N, Espin-Garcia O, Xu W, Smith MI, Griffiths AM, Moayyedi P, Turner D, Seidman EG, Steinhart AH, Marshall JK, Jacobson K, Mack D, Huynh H, Bernstein CN, Paterson AD, Croitoru K, Crohns and Colitis Canada Genetic Environmental Microbial Project Research Consortium
RECONSTITUTION GUIDE To prepare Tirzepatide for laboratory use: Allow vial to reach room temperature before opening Add sterile water or suitable buffer slowly along the vial wall Typical working concentration: 0.52 mg/mL Gently swirl until fully dissolved (do not shake vigorously) Aliquot into smaller volumes to minimize freeze-thaw cycles Maintain sterile conditions throughout the process
It was approved by the FDA for type 2 diabetes in 2010 and for chronic weight management in 2014
JAMA Network Open, 3 (10), e2020969